Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nonprescribed Substance Use in the General Hospital: A Retrospective Study.
Dockery LM, Kast KA, Smith M, Stewart LS, Reese T, Wiese AD, Shah MV, Marcovitz DE. Dockery LM, et al. Among authors: shah mv. J Acad Consult Liaison Psychiatry. 2024 Oct 5:S2667-2960(24)00105-8. doi: 10.1016/j.jaclp.2024.09.006. Online ahead of print. J Acad Consult Liaison Psychiatry. 2024. PMID: 39370110
Effect of a Co-Located Bridging Recovery Initiative on Hospital Length of Stay Among Patients With Opioid Use Disorder: The BRIDGE Randomized Clinical Trial.
Marcovitz D, Dear ML, Donald R, Edwards DA, Kast KA, Le TDV, Shah MV, Ferrell J, Gatto C, Hennessy C, Buie R, Rice TW, Sullivan W, White KD, Van Winkle G, Wolf R, Lindsell CJ; Vanderbilt Learning Healthcare System Platform Investigators. Marcovitz D, et al. Among authors: shah mv. JAMA Netw Open. 2024 Feb 5;7(2):e2356430. doi: 10.1001/jamanetworkopen.2023.56430. JAMA Netw Open. 2024. PMID: 38411964 Free PMC article. Clinical Trial.
Venetoclax in combination with fludarabine, cytarabine, granulocyte colony stimulating factor, and idarubicin (FLAG-Ida) in patients with acute leukemia of ambiguous lineage and acute lymphoblastic leukemia.
Tessier S, McCullough KB, Gangat N, Begna KH, Saliba AN, Mangoankar AA, Shah MV, Hogan WJ, Patnaik MM, Al-Kali A, Alkhateeb HB. Tessier S, et al. Among authors: shah mv. Leuk Lymphoma. 2025 Jan 16:1-5. doi: 10.1080/10428194.2024.2443017. Online ahead of print. Leuk Lymphoma. 2025. PMID: 39817316 No abstract available.
What have we learned about TP53-mutated acute myeloid leukemia?
Shahzad M, Amin MK, Daver NG, Shah MV, Hiwase D, Arber DA, Kharfan-Dabaja MA, Badar T. Shahzad M, et al. Among authors: shah mv. Blood Cancer J. 2024 Nov 19;14(1):202. doi: 10.1038/s41408-024-01186-5. Blood Cancer J. 2024. PMID: 39562552 Free PMC article. Review.
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial.
Wang ES, Issa GC, Erba HP, Altman JK, Montesinos P, DeBotton S, Walter RB, Pettit K, Savona MR, Shah MV, Kremyanskaya M, Baer MR, Foran JM, Schiller G, Adès L, Heiblig M, Berthon C, Peterlin P, Rodríguez-Arbolí E, Salamero O, Patnaik MM, Papayannidis C, Grembecka J, Cierpicki T, Clegg B, Ray J, Linhares BM, Nie K, Mitra A, Ahsan JM, Tabachri M, Soifer HS, Corum D, Leoni M, Dale S, Fathi AT. Wang ES, et al. Among authors: shah mv. Lancet Oncol. 2024 Oct;25(10):1310-1324. doi: 10.1016/S1470-2045(24)00386-3. Lancet Oncol. 2024. PMID: 39362248 Clinical Trial.
Blood neurofilament light chain measurements in adults with CNS histiocytic neoplasms.
Banks SA, Decker P, Flanagan EP, Zekeridou A, Go RS, Abeykoon JP, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Bach CR, Eckel-Passow JE, Tobin WO; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group and Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic. Banks SA, et al. Among authors: shah mv. Blood Cancer J. 2024 Sep 5;14(1):153. doi: 10.1038/s41408-024-01118-3. Blood Cancer J. 2024. PMID: 39237493 Free PMC article. No abstract available.
Clonal heterogeneity in STAG2m myeloid neoplasms: the Mayo Clinic experience.
Katamesh B, Nanaa A, He R, Viswanatha D, Greipp PT, Bessonen K, Nguyen P, Jevremovic D, Yi CA, Foran J, Begna K, Gangat N, Mangaonkar A, Saliba AN, Patnaik MM, Hogan WJ, Litzow M, Tefferi A, Shah MV, Alkhateeb HB, Al-Kali A. Katamesh B, et al. Among authors: shah mv. Ann Hematol. 2024 Oct;103(10):4333-4336. doi: 10.1007/s00277-024-05971-x. Epub 2024 Aug 28. Ann Hematol. 2024. PMID: 39196377 No abstract available.
244 results